Aliment Capital
Status
ACTIVE
Global HQ
Santa Monica, United States
Countries of investment
- United States
- Israel
- Canada
- United Kingdom
Investment stages
- Series B
- Series C
- Growth
Industries
- FoodTech
- AgriFood
- AgTech
- Crop Sciences
- Precision Agriculture
- Supply Chain
- Food Science
- Nutrition
About
Aliment Capital (formerly Pontifax AgTech) is a Santa Monica-based growth capital investor focused on food and agriculture technology. Their portfolio spans crop biotech, precision agriculture, supply chain, and nutrition companies across the US and Israel. The firm invests at Series B and beyond with $483M in assets under management.
Aliment Capital (formerly Pontifax AgTech) is a Santa Monica-based growth capital investor focused on food and agriculture technology. Their portfolio spans crop biotech, precision agriculture, supply chain, and nutrition companies across the US and Israel. The firm invests at Series B and beyond with $483M in assets under management.
Investment Thesis
Aliment Capital is a growth-stage venture capital firm investing in disruptive companies that improve the efficiency, resilience, and sustainability of the global food and agriculture sector. They partner with established businesses at Series B and beyond that have proven technologies addressing the food and agriculture value chain, nutrition, and human health. The firm differentiates itself through its $483M AUM, proprietary global ecosystem of technical advisors, and strong positions in the US and Israel — two leading centers of AgTech innovation.
Manager's Experience
Co-Founders and Managing Partners Ben Belldegrun and Philip Erlanger launched the firm in 2013 as Pontifax AgTech (rebranded to Aliment Capital in 2022), bringing growth equity discipline and scientific rigor to late-stage food and agriculture investing. Belldegrun holds credentials from a prominent biotech investing family (his father founded Kite Pharma), while Erlanger contributes institutional finance experience. With $483M across Fund I ($105M) and Fund II ($302M) backed by university endowments, pension funds, and foundations, the Los Angeles-based team targets Series B+ investments in proven agtech and biotech companies, with notable exits including Blue River Technology (acquired by John Deere, ~4x return) and Precision Biosciences (IPO).
Team
Ben Belldegrun – Co-Founder / Managing Partner
Philip Erlanger – Co-Founder / Managing Partner
Alex Mittelman – Principal
Portfolio
Blue River Technology
Precision Biosciences
Caribou Biosciences
AgBiome
Anuvia
Concentric
Tropic Biosciences
Conservis
FoodLogiQ
Bouqs
Fabric
Pairwise
Provivi
Hazel Technologies
Kate Farms
Fruitist